Sarah Ahn

2.2k total citations · 3 hit papers
15 papers, 1.4k citations indexed

About

Sarah Ahn is a scholar working on Oncology, Immunology and Biomedical Engineering. According to data from OpenAlex, Sarah Ahn has authored 15 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Immunology and 6 papers in Biomedical Engineering. Recurrent topics in Sarah Ahn's work include CAR-T cell therapy research (13 papers), Nanowire Synthesis and Applications (5 papers) and Immune Cell Function and Interaction (4 papers). Sarah Ahn is often cited by papers focused on CAR-T cell therapy research (13 papers), Nanowire Synthesis and Applications (5 papers) and Immune Cell Function and Interaction (4 papers). Sarah Ahn collaborates with scholars based in United States, China and Spain. Sarah Ahn's co-authors include Gianpietro Dotti, Quanyin Hu, Qian Chen, Elena Dukhovlinova, Zhen Gu, Edikan A. Ogunnaike, Frances S. Ligler, Guojun Chen, Chao Wang and Barbara Savoldo and has published in prestigious journals such as Advanced Materials, Nature Biotechnology and PLoS ONE.

In The Last Decade

Sarah Ahn

14 papers receiving 1.4k citations

Hit Papers

Photothermal Therapy Promotes Tumor Infiltration and Anti... 2019 2026 2021 2023 2019 2021 2022 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Ahn United States 11 796 786 514 408 209 15 1.4k
Rachel A. Burga United States 19 890 1.1× 518 0.7× 646 1.3× 266 0.7× 189 0.9× 32 1.5k
Adham S. Bear United States 13 964 1.2× 500 0.6× 643 1.3× 483 1.2× 217 1.0× 25 1.5k
Edikan A. Ogunnaike United States 8 362 0.5× 513 0.7× 285 0.6× 235 0.6× 101 0.5× 13 793
Adam Grippin United States 14 463 0.6× 261 0.3× 402 0.8× 362 0.9× 102 0.5× 47 1.1k
David Zhang United States 17 431 0.5× 449 0.6× 417 0.8× 484 1.2× 170 0.8× 25 1.3k
Sirkka B. Stephan United States 11 1.3k 1.7× 1.1k 1.4× 1.2k 2.4× 1.1k 2.7× 417 2.0× 14 2.6k
Amin Aalipour United States 15 317 0.4× 572 0.7× 145 0.3× 386 0.9× 97 0.5× 19 1.1k
Elizabeth L. Siegler United States 14 910 1.1× 444 0.6× 398 0.8× 346 0.8× 198 0.9× 37 1.2k
Albert Lo United States 17 2.0k 2.5× 620 0.8× 801 1.6× 1.0k 2.5× 482 2.3× 18 2.8k
Bart Thaçi United States 18 405 0.5× 253 0.3× 212 0.4× 551 1.4× 328 1.6× 34 1.3k

Countries citing papers authored by Sarah Ahn

Since Specialization
Citations

This map shows the geographic impact of Sarah Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Ahn more than expected).

Fields of papers citing papers by Sarah Ahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Ahn. The network helps show where Sarah Ahn may publish in the future.

Co-authorship network of co-authors of Sarah Ahn

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Ahn. A scholar is included among the top collaborators of Sarah Ahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Ahn. Sarah Ahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Jové, Veronica, Luigi Celentano, Sarah Ahn, et al.. (2025). Abstract 5362: Molecular profiling of SW-682, a pan-TEAD inhibitor, as monotherapy and in combination with other treatments across tumor types. Cancer Research. 85(8_Supplement_1). 5362–5362.
2.
Ogunnaike, Edikan A., Sarah Ahn, Anton Jansson, et al.. (2022). Bioinstructive implantable scaffolds for rapid in vivo manufacture and release of CAR-T cells. Nature Biotechnology. 40(8). 1250–1258. 138 indexed citations breakdown →
3.
Lichtman, Eben I., Hongwei Du, Peishun Shou, et al.. (2021). Preclinical Evaluation of B7-H3–specific Chimeric Antigen Receptor T Cells for the Treatment of Acute Myeloid Leukemia. Clinical Cancer Research. 27(11). 3141–3153. 57 indexed citations
4.
Ranganathan, Raghuveer, Peishun Shou, Sarah Ahn, et al.. (2021). CAR T cells Targeting Human Immunoglobulin Light Chains Eradicate Mature B-cell Malignancies While Sparing a Subset of Normal B Cells. Clinical Cancer Research. 27(21). 5951–5960. 18 indexed citations
5.
Hu, Quanyin, Hongjun Li, Edikan Archibong, et al.. (2021). Inhibition of post-surgery tumour recurrence via a hydrogel releasing CAR-T cells and anti-PDL1-conjugated platelets. Nature Biomedical Engineering. 5(9). 1038–1047. 292 indexed citations breakdown →
6.
Wang, Kai, Yu‐Hui Chen, Sarah Ahn, et al.. (2020). GD2-specific CAR T cells encapsulated in an injectable hydrogel control retinoblastoma and preserve vision. Nature Cancer. 1(10). 990–997. 88 indexed citations
7.
Ma, Xingcong, Peishun Shou, Christof C. Smith, et al.. (2020). Interleukin-23 engineering improves CAR T cell function in solid tumors. Nature Biotechnology. 38(4). 448–459. 197 indexed citations
8.
Sun, Chuang, Peishun Shou, Hongwei Du, et al.. (2020). THEMIS-SHP1 Recruitment by 4-1BB Tunes LCK-Mediated Priming of Chimeric Antigen Receptor-Redirected T Cells. Cancer Cell. 37(2). 216–225.e6. 100 indexed citations
9.
Liu, Lumei, Sarah Ahn, Gianpietro Dotti, et al.. (2020). Activation and degranulation of CAR-T cells using engineered antigen-presenting cell surfaces. PLoS ONE. 15(9). e0238819–e0238819. 6 indexed citations
10.
Li, Guangming, Yu‐Hui Chen, Kyogo Suzuki, et al.. (2020). THEMIS-SHP1 Recruitment by 4-1BB Tunes LCK-Mediated Priming of Chimeric Antigen Receptor-Redirected T Cells. UNC Libraries. 1 indexed citations
11.
Ogunnaike, Edikan A., et al.. (2020). Scaffold‐Mediated Static Transduction of T Cells for CAR‐T Cell Therapy. Advanced Healthcare Materials. 9(14). e2000275–e2000275. 19 indexed citations
12.
Ahn, Sarah, Jingjing Li, Chuang Sun, et al.. (2019). Cancer Immunotherapy with T Cells Carrying Bispecific Receptors That Mimic Antibodies. Cancer Immunology Research. 7(5). 773–783. 20 indexed citations
13.
Chen, Qian, Quanyin Hu, Elena Dukhovlinova, et al.. (2019). Photothermal Therapy: Photothermal Therapy Promotes Tumor Infiltration and Antitumor Activity of CAR T Cells (Adv. Mater. 23/2019). Advanced Materials. 31(23). 25 indexed citations
14.
Chen, Qian, Quanyin Hu, Elena Dukhovlinova, et al.. (2019). Photothermal Therapy Promotes Tumor Infiltration and Antitumor Activity of CAR T Cells. Advanced Materials. 31(23). e1900192–e1900192. 400 indexed citations breakdown →
15.
Ahn, Sarah, et al.. (2016). (p)ppGpp-Dependent Persisters Increase the Fitness of Escherichia coli Bacteria Deficient in Isoaspartyl Protein Repair. Applied and Environmental Microbiology. 82(17). 5444–5454. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026